Alinma Bank (TADAWUL:1150)

Intra-Cellular Therapies Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7,303	6,409	5,173	3,573	3,211	6,268
Investment Securities	46,041	45,483	40,587	36,876	30,912	27,340
Trading Asset Securities	3,855	3,648	2,793	1,652	2,366	2,186
Total Investments	49,896	49,131	43,381	38,529	33,278	29,526
Gross Loans	213,687	226,374	193,412	162,721	139,353	124,166
Allowance for Loan Losses	-4,252	-3,759	-4,433	-3,981	-4,041	-3,266
Other Adjustments to Gross Loans	-	-19,916	-15,129	-12,117	-8,903	-9,677
Net Loans	209,435	202,698	173,850	146,623	126,409	111,224
Property, Plant & Equipment	3,604	2,292	2,032	1,942	1,917	2,103
Other Intangible Assets	-	1,109	856.63	690.57	466.09	262.36
Other Receivables	1,611	1,372	831.05	475.66	428.15	395.79
Restricted Cash	11,564	11,438	8,989	7,484	6,705	6,383
Other Current Assets	-	386.21	414.46	128.52	98.66	97.92
Other Real Estate Owned & Foreclosed	-	659.85	474.67	435.91	244.44	474.63
Other Long-Term Assets	3,809	1,333	713.67	555.38	720.28	143.01
Total Assets	287,222	276,827	236,715	200,436	173,476	156,877
Accounts Payable	-	1,932	1,640	1,906	1,746	1,519
Accrued Expenses	-	489.51	373.45	337.72	339.3	308.62
Interest Bearing Deposits	114,964	115,291	108,945	71,281	49,737	56,614
Non-Interest Bearing Deposits	112,099	103,379	81,207	85,813	78,704	69,395
Total Deposits	227,063	218,671	190,151	157,094	128,442	126,009
Short-Term Borrowings	4,624	6,247	5,291	4,571	7,858	756.94
Current Portion of Leases	-	111.51	109.23	101.27	103.67	100.26
Current Income Taxes Payable	-	670.41	556.32	413.76	311.55	227.02
Other Current Liabilities	-	4,250	1,982	2,143	1,704	1,882
Long-Term Leases	-	233.9	256.86	274.83	278.31	289.05
Long-Term Unearned Revenue	-	989.6	749.87	548.44	495.96	-
Pension & Post-Retirement Benefits	-	537.47	485.25	464.01	438.07	404.38
Other Long-Term Liabilities	12,584	1,254	786.01	706.11	1,048	951.33
Total Liabilities	244,271	235,386	202,381	168,560	142,765	132,448
Common Stock	25,000	25,000	20,000	20,000	20,000	20,000
Retained Earnings	9,379	8,025	4,497	7,450	5,683	4,352
Treasury Stock	-180.96	-203.96	-225.61	-66.02	-94.16	-100
Comprehensive Income & Other	8,754	8,621	10,062	4,493	5,123	177.05
Shareholders' Equity	42,952	41,442	34,334	31,876	30,711	24,429
Total Liabilities & Equity	287,222	276,827	236,715	200,436	173,476	156,877
Total Debt	4,624	6,592	5,657	4,947	8,240	1,146
Net Cash (Debt)	6,534	3,464	2,309	278.56	-2,664	7,307
Net Cash Growth	2057.90%	50.01%	729.07%	-	-	125.69%
Net Cash Per Share	2.63	1.39	0.93	0.11	-1.07	2.94
Filing Date Shares Outstanding	2,487	2,486	2,487	2,489	2,485	2,484
Total Common Shares Outstanding	2,487	2,486	2,487	2,489	2,485	2,484
Book Value Per Share	13.75	13.15	11.79	10.80	10.35	9.83
Tangible Book Value	42,952	40,333	33,477	31,186	30,245	24,166
Tangible Book Value Per Share	13.75	12.71	11.45	10.52	10.16	9.73

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.